ADMA Biologics Commences Pivotal Phase III Clinical Study of RI-002 in PIDD …PipelineReview.com (press release)HACKENSACK, NJ, USA I March 7, 2013 I ADMA Biologics, Inc. (ADMA), a specialty immune globulin company that develops, manufactures and inte…
ACC: Viagra Withers in Heart Failure Trial – MedPage Today
|
ACC: Viagra Withers in Heart Failure Trial
MedPage Today “There was really a strong rationale from existing studies to use sildenafil in heart failure,” Redfield explained. “This was a small, placebo controlled, double-blind trial in 216 patients. This was a proof of concept trial with the idea of obtaining … |
Arnie's Rebounding World: My New Occupation As Multiple Myeloma Patient – The Myeloma Beacon
|
Arnie’s Rebounding World: My New Occupation As Multiple Myeloma Patient
The Myeloma Beacon In the last three years or so, I have had a second autologous stem cell transplant, multiple rounds of novel myeloma therapies, traditional chemotherapy, a donor (allogeneic) stem cell transplant in August, and radiation therapy last month. I had hoped … |
American College of Cardiology 2013 Abstracts Explore PGx, Prognostic … – GenomeWeb
|
American College of Cardiology 2013 Abstracts Explore PGx, Prognostic …
GenomeWeb … for marketing in the US. The 510(k) clearance further extends Life Tech’s presence in the diagnostics space, following its launch of the Pervenio Lung RS test, and last month’s FDA clearance for its 3500 Dx Genetic Analyzers and SeCore HLA typing kits. |
Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance … – Newswise (press release)
 Hutchinson Center A Life of Science |
Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance …
Newswise (press release) Storb is a world-renowned scientist, oncology doctor and expert in bone-marrow transplantation and blood cancer. Additionally, he is a founder of one of the most essential cancer research … Paul O’Donnell, MD, PhD, member of the Clinical Research … Fred Hutchinson Cancer Research Center names seasoned media executive as …Hutchinson Center A Life of Science |
Cardiac Biomarker ST2 Identifies Chronic Heart Failure Patients To Benefit … – PharmaLive (press release) (subscription)
|
Cardiac Biomarker ST2 Identifies Chronic Heart Failure Patients To Benefit …
PharmaLive (press release) (subscription) “ST2 is unlike any biomarker in heart failure because of its enduring prognostic strength, but now, as evidenced by the encouraging results from this study, ST2 holds the final link in potentially improving outcomes for heart failure patients through … |
Anemia drugs does not improve health of anemic heart failure patients – EurekAlert (press release)
 Health Newstrack |
Anemia drugs does not improve health of anemic heart failure patients
EurekAlert (press release) Researchers from Sahlgrenska Academy, University of Gothenburg, Sweden, have found that a commonly used drug to treat anemia in heart failure patients does not improve patients’ health, nor does it reduce their risk of death from heart failure. Results … ACC: Anemia Drug No Help in Heart FailureMedPage Today Anemia treatment not beneficial in heart failureFamily Practice News Digital Network ACC: Darbepoetin Alfa Doesn’t Up Outcome in Heart FailureDoctors Lounge Forbes all 5 news articles » |
Erectile dysfunction drug fails for diastolic heart failure patients – Science Codex
 RedOrbit |
Erectile dysfunction drug fails for diastolic heart failure patients
Science Codex SAN FRANCISCO (March 11, 2013) — Despite high expectations for a commonly used erectile dysfunction drug to treat patients with diastolic heart failure, no beneficial effects were found in a study presented today at the American College of Cardiology … ASTRONAUT trial finds no beneficial effects of aliskiren in recently …News-Medical.net Viagra No Help in Heart FailureMedPage Today Sildenafil falls short for heart failure with preserved ejection fractionFamily Practice News Digital Network RedOrbit –French Tribune –Doctors Lounge all 17 news articles » |
No benefit found from BP drug in treatment of recently hospitalized heart … – Medical Xpress
|
No benefit found from BP drug in treatment of recently hospitalized heart …
Medical Xpress Despite high hopes that a blood pressure-lowering medication called aliskiren would help people following hospitalization for heart failure, no beneficial effects were found, according to research presented today at the American College of Cardiology’s … Combination therapy for heart failure does not reduce risk of CV death or …EurekAlert (press release) Direct renin inhibitor aliskiren flops as add-on therapy in systolic HF: ASTRONAUTTheHeart.Org ASTRONAUT Study: No Significant Post-Discharge Mortality Benefit Seen with …Monthly Prescribing Reference |
Screenings, targeted care reduce heart failure in at-risk patients – Medical Xpress
Screenings, targeted care reduce heart failure in at-risk patientsMedical XpressThe five-year STOP-HF study enrolled asymptomatic patients over 40 years of age with risk factors for heart failure and randomized them into an intervention and a control g…